Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJ NYSE:PG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$231.69+1.0%$234.19$149.04▼$251.71$552.02B0.277.68 million shs5.24 million shsPGProcter & Gamble$143.40+0.7%$145.11$137.62▼$170.99$331.69B0.418.69 million shs6.30 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson+1.08%+0.47%+2.42%-4.37%+51.27%PGProcter & Gamble+0.57%+0.52%+0.65%-10.80%-13.35%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$231.69+1.0%$234.19$149.04▼$251.71$552.02B0.277.68 million shs5.24 million shsPGProcter & Gamble$143.40+0.7%$145.11$137.62▼$170.99$331.69B0.418.69 million shs6.30 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson+1.08%+0.47%+2.42%-4.37%+51.27%PGProcter & Gamble+0.57%+0.52%+0.65%-10.80%-13.35%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.74Moderate Buy$253.049.22% UpsidePGProcter & Gamble 2.55Moderate Buy$161.0612.31% UpsideCurrent Analyst Ratings BreakdownLatest PG and JNJ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2026JNJJohnson & Johnson Johnson RiceSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Outperform5/13/2026JNJJohnson & Johnson Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$265.004/27/2026PGProcter & Gamble UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$166.00 ➝ $172.004/27/2026PGProcter & Gamble Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$163.004/27/2026PGProcter & Gamble EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$162.004/27/2026PGProcter & Gamble Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$158.00 ➝ $164.004/27/2026PGProcter & Gamble Rothschild & Co RedburnSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$157.00 ➝ $155.004/27/2026PGProcter & Gamble TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$142.00 ➝ $150.004/24/2026JNJJohnson & Johnson Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)4/24/2026PGProcter & Gamble Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$142.00 ➝ $145.004/23/2026PGProcter & Gamble BNP Paribas ExaneSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$172.00 ➝ $165.00(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$94.19B5.92$14.27 per share16.24$33.73 per share6.87PGProcter & Gamble$84.28B3.96$8.43 per share17.02$23.18 per share6.19Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$26.80B$8.6526.7918.422.2521.83%32.60%13.29%7/15/2026 (Estimated)PGProcter & Gamble$15.97B$6.8420.9720.236.1119.16%32.00%13.27%8/4/2026 (Estimated)Latest PG and JNJ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/24/2026Q3 2026PGProcter & Gamble$1.56$1.59+$0.03$1.63$21.52 billion$21.24 billion4/14/2026Q1 2026JNJJohnson & Johnson$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.202.24%+5.25%60.12%64 YearsPGProcter & Gamble$4.353.03%+6.13%63.60%70 YearsLatest PG and JNJ DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/14/2026JNJJohnson & Johnsonquarterly$1.342.23%5/26/20265/26/20266/9/20264/14/2026PGProcter & Gamblequarterly$1.08852.94%4/24/20264/24/20265/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.461.030.77PGProcter & Gamble0.440.730.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%PGProcter & Gamble65.77%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%PGProcter & Gamble0.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson138,2002.41 billion2.40 billionOptionablePGProcter & Gamble109,0002.33 billion2.32 billionOptionablePG and JNJ HeadlinesRecent News About These CompaniesP&G Extends Native Brand Into Sensitive Skin As Shares Trade Below TargetsMay 21 at 7:23 PM | finance.yahoo.com1 Profitable Stock with Exciting Potential and 2 We IgnoreMay 21 at 7:23 PM | finance.yahoo.comYou Do Not Need 30 Years of Federal Service to Build a Pension. Here Is the $495,000 Dividend Portfolio That Pays Like OneMay 21 at 9:19 AM | 247wallst.comProcter & Gamble Company (The) $PG Shares Bought by FourThought Financial Partners LLCMay 21 at 8:09 AM | marketbeat.comProcter & Gamble Company (The) $PG Shares Purchased by Mach 1 Financial Group LLCMay 21 at 7:29 AM | marketbeat.comRathbones Group PLC Grows Stock Holdings in Procter & Gamble Company (The) $PGMay 21 at 6:08 AM | marketbeat.comAspen Investment Management Inc Increases Stock Holdings in Procter & Gamble Company (The) $PGMay 21 at 3:26 AM | marketbeat.comABN Amro Investment Solutions Raises Position in Procter & Gamble Company (The) $PGMay 21 at 3:18 AM | marketbeat.com1 profitable stock with exciting potential and 2 we ignoreMay 20 at 8:58 AM | msn.comInflation rising: how consumers are remaining resilientMay 20 at 8:58 AM | finance.yahoo.comHarvest Portfolios Group Inc. Acquires 12,739 Shares of Procter & Gamble Company (The) $PGMay 20 at 5:49 AM | marketbeat.comPNC Financial Services Group Inc. Sells 230,596 Shares of Procter & Gamble Company (The) $PGMay 20 at 5:33 AM | marketbeat.comCullen Frost Bankers Inc. Sells 13,770 Shares of Procter & Gamble Company (The) $PGMay 20 at 4:20 AM | marketbeat.comFairtree Asset Management Pty Ltd Makes New Investment in Procter & Gamble Company (The) $PGMay 20 at 4:12 AM | marketbeat.comFideuram Intesa Sanpaolo Private Banking S.P.A. Buys New Shares in Procter & Gamble Company (The) $PGMay 20 at 3:55 AM | marketbeat.comProcter & Gamble Company (The) $PG Shares Purchased by GSA Capital Partners LLPMay 20 at 3:54 AM | marketbeat.comProcter & Gamble: A High-Quality Dividend King That Still Lacks A Good Margin Of SafetyMay 20 at 3:31 AM | seekingalpha.comAssessing Procter & Gamble (PG) Valuation After Q3 Earnings Beat And Ongoing Productivity PlanMay 19 at 12:09 AM | finance.yahoo.comGlobal Oral Care Market Outlook 2026-2036: Daily Replenishment Demand and Premiumization Drive Growth for Colgate-Palmolive, Procter & Gamble, and UnileverMay 19 at 12:09 AM | finance.yahoo.comMost Retirees Skip Over Vanguard's $100 Billion VYM Despite Its 2.9 Percent Yield and Almost Zero MaintenanceMay 19 at 1:40 PM | 247wallst.com3 Dividend Kings to Buy and Hold for 20 YearsMay 19 at 11:30 AM | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026AMD’s Breakout Isn’t the Story—This Catalyst IsBy Thomas Hughes | April 24, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Procter & Gamble Gave the Market What It Wanted: A Reason to BuyBy Thomas Hughes | April 24, 2026PG and JNJ Company DescriptionsJohnson & Johnson NYSE:JNJ$231.69 +2.37 (+1.03%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$231.50 -0.19 (-0.08%) As of 05/21/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.Procter & Gamble NYSE:PG$143.40 +0.96 (+0.68%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$143.34 -0.06 (-0.04%) As of 05/21/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
